# | Drug | Count |
---|---|---|
0 | METHOTREXATE SODIUM | 273 |
1 | TOCILIZUMAB | 273 |
2 | ABATACEPT | 272 |
3 | ETANERCEPT | 272 |
4 | INFLIXIMAB | 272 |
5 | ADALIMUMAB | 271 |
6 | SULFASALAZINE | 271 |
7 | ANAKINRA | 269 |
8 | METHOTREXATE | 257 |
9 | PREDNISONE | 257 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | TRIAMCINOLONE HEXACETONIDE | 119 | 0.5694 |
1 | VACCINIA IMMUNE GLOBULIN (HUMAN) | 1 | 0.0667 |
2 | ANAKINRA | 269 | 0.0230 |
3 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 106 | 0.0104 |
4 | TRIAMCINOLONE ACETONIDE | 106 | 0.0051 |
5 | SULFASALAZINE | 271 | 0.0046 |
6 | HUMAN IMMUNOGLOBULIN G | 22 | 0.0040 |
7 | TOCILIZUMAB | 273 | 0.0034 |
8 | ABATACEPT | 272 | 0.0027 |
9 | HYDROXYCHLOROQUINE SULFATE | 151 | 0.0021 |
# | Drug class | Count |
---|---|---|
0 | Tumor Necrosis Factor Blocker [EPC] | 287 |
1 | Interleukin-6 Receptor Antagonist [EPC] | 273 |
2 | Aminosalicylate [EPC] | 272 |
3 | Selective T Cell Costimulation Modulator [EPC] | 272 |
4 | Interleukin-1 Receptor Antagonist [EPC] | 269 |
5 | Corticosteroid [EPC] | 267 |
6 | Folate Analog Metabolic Inhibitor [EPC] | 257 |
7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 204 |
8 | Vitamin B12 [EPC] | 50 |
9 | Vitamin C [EPC] | 50 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Interleukin-1 Receptor Antagonist [EPC] | 269 | 0.0230 |
1 | Human Immunoglobulin G [EPC] | 23 | 0.0039 |
2 | Interleukin-6 Receptor Antagonist [EPC] | 273 | 0.0031 |
3 | Aminosalicylate [EPC] | 272 | 0.0029 |
4 | Selective T Cell Costimulation Modulator [EPC] | 272 | 0.0027 |
5 | Folate Analog Metabolic Inhibitor [EPC] | 257 | 0.0008 |
6 | Tumor Necrosis Factor Blocker [EPC] | 287 | 0.0004 |
7 | Corticosteroid [EPC] | 267 | 0.0003 |
8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 204 | 0.0002 |
9 | Vitamin D [EPC] | 50 | 0.0002 |